100 related articles for article (PubMed ID: 2131044)
1. Nuclear hormone receptor variants: their role in malignancy and progression to hormone resistance in cancer.
Sluyser M
Anticancer Drugs; 1990 Dec; 1(2):127-32. PubMed ID: 2131044
[TBL] [Abstract][Full Text] [Related]
2. T47DCO cells, genetically unstable and containing estrogen receptor mutations, are a model for the progression of breast cancers to hormone resistance.
Graham ML; Krett NL; Miller LA; Leslie KK; Gordon DF; Wood WM; Wei LL; Horwitz KB
Cancer Res; 1990 Oct; 50(19):6208-17. PubMed ID: 2400987
[TBL] [Abstract][Full Text] [Related]
3. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
Kawai H; Li H; Chun P; Avraham S; Avraham HK
Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
[TBL] [Abstract][Full Text] [Related]
4. Steroid receptors and their role in the biology and control of breast cancer growth.
Cordera F; Jordan VC
Semin Oncol; 2006 Dec; 33(6):631-41. PubMed ID: 17145341
[TBL] [Abstract][Full Text] [Related]
5. [New concepts on hormone dependence in breast cancer].
Levin E; Caruso SP; Actis AM; de Levin RW
Medicina (B Aires); 1997; 57(1):95-103. PubMed ID: 9435378
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor mutations in breast cancer.
Fuqua SA; Chamness GC; McGuire WL
J Cell Biochem; 1993 Feb; 51(2):135-9. PubMed ID: 8440747
[TBL] [Abstract][Full Text] [Related]
7. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
8. Nuclear hormone receptor variants: their role in malignancy and progression to hormone resistance in cancer.
Sluyser M
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():48-53. PubMed ID: 1666242
[TBL] [Abstract][Full Text] [Related]
9. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.
Lapidus RG; Ferguson AT; Ottaviano YL; Parl FF; Smith HS; Weitzman SA; Baylin SB; Issa JP; Davidson NE
Clin Cancer Res; 1996 May; 2(5):805-10. PubMed ID: 9816234
[TBL] [Abstract][Full Text] [Related]
10. Membrane-initiated steroid signaling action of estrogen and breast cancer.
Song RX
Semin Reprod Med; 2007 May; 25(3):187-97. PubMed ID: 17447208
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.
Latil A; Bièche I; Vidaud D; Lidereau R; Berthon P; Cussenot O; Vidaud M
Cancer Res; 2001 Mar; 61(5):1919-26. PubMed ID: 11280747
[TBL] [Abstract][Full Text] [Related]
12. An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer.
Zhang QX; Borg A; Fuqua SA
Cancer Res; 1993 Dec; 53(24):5882-4. PubMed ID: 8261397
[TBL] [Abstract][Full Text] [Related]
13. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
14. Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers?
Sheikh MS; Garcia M; Pujol P; Fontana JA; Rochefort H
Invasion Metastasis; 1994-1995; 14(1-6):329-36. PubMed ID: 7657526
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor mutations in tamoxifen-resistant breast cancer.
Karnik PS; Kulkarni S; Liu XP; Budd GT; Bukowski RM
Cancer Res; 1994 Jan; 54(2):349-53. PubMed ID: 8275466
[TBL] [Abstract][Full Text] [Related]
16. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.
Pietras RJ; Arboleda J; Reese DM; Wongvipat N; Pegram MD; Ramos L; Gorman CM; Parker MG; Sliwkowski MX; Slamon DJ
Oncogene; 1995 Jun; 10(12):2435-46. PubMed ID: 7784095
[TBL] [Abstract][Full Text] [Related]
17. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer.
Ghosh MG; Thompson DA; Weigel RJ
Cancer Res; 2000 Nov; 60(22):6367-75. PubMed ID: 11103799
[TBL] [Abstract][Full Text] [Related]
18. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
19. Hormone receptors and Japanese breast cancer.
Matsumoto K; Kitamura Y; Sugano H
Acta Pathol Jpn; 1982; 32 Suppl 1():145-54. PubMed ID: 6764994
[TBL] [Abstract][Full Text] [Related]
20. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line.
Castles CG; Fuqua SA; Klotz DM; Hill SM
Cancer Res; 1993 Dec; 53(24):5934-9. PubMed ID: 8261406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]